In the published article, there was an error in the legend for Figure 12 as published.
[As in the prior 5 figures, equimolar adaptor/cargo complexes were internalized in growth media for 1 h prior to washing (PBS x2) and imaging in media containing NucBlue.]. The corrected legend appears below.
“Colocalization of MBP-EP-CBS cargos and pGFP-CaM during comparison of the internalization of the five MBP-EP-CBS cargos at two concentrations. Simultaneous internalization of the five 550-labeled MBP-EP-CBS cargos with equimolar pGFPCaM at complex concentrations of (A) 1000 nM or (B) 200 nM. Equimolar adaptor/cargo complexes were internalized in growth media containing NucBlue and imaged with the complex present between 40–60 min.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
cell-penetrating peptides, protein transduction domains (PTD), endolytic peptides, endocytosis, calmodulin (CAM)
Citation
Morris DP, Snipes LC, Hill SA, Woods MM, Mbugua MM, Wade LR and McMurry JL (2023) Corrigendum: A reversible cell penetrating peptide-cargo linkage allows dissection of cell penetrating peptide-and cargo- dependent effects on internalization and identifies new functionalities of putative endolytic peptides. Front. Pharmacol. 14:1152506. doi: 10.3389/fphar.2023.1152506
Received
27 January 2023
Accepted
30 March 2023
Published
18 April 2023
Volume
14 - 2023
Edited and reviewed by
Nian-Qiu Shi, Jilin Medical University, China
Updates
Copyright
© 2023 Morris, Snipes, Hill, Woods, Mbugua, Wade and McMurry.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jonathan L. McMurry, jmcmurr1@kennesaw.edu
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.